WS05.4 Clinical effectiveness results from the first interim analysis of the VOCAL study; an observational study of ivacaftor in patients with cystic fibrosis and selected non-G551D gating mutations

C Castellani,C Colombo,C.K Van Der Ent,N.J Simmonds,N Kinnman,M Hassan,C Desouza,A Kaviya

doi:10.1016/s1569-1993(18)30146-2

WS05.4 Clinical effectiveness results from the first interim analysis of the VOCAL study; an observational study of ivacaftor in patients with cystic fibrosis and selected non-G551D gating mutations

C Castellani, C Colombo + Show 6 more

Open Access

https://doi.org/10.1016/s1569-1993(18)30146-2

Copy DOI

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society	Publication Date: Jun 1, 2018
Citations: 3	License type: publisher-specific-oa

#Ivacaftor In Patients #Cystic Fibrosis + Show 4 more

Abstract
Full-Text PDF
Similar Papers

Abstract

WS05.4 Clinical effectiveness results from the first interim analysis of the VOCAL study; an observational study of ivacaftor in patients with cystic fibrosis and selected non-G551D gating mutations

Full Text